I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in tech and innovation within the industry. With a strong background in research and development, Ivan brings a unique perspective on the evolving landscape of telehealth. Today, we’re diving into the
Nasopharyngeal carcinoma, a challenging foe of the throat, demands a cutting-edge weapon. Standard radiotherapy often seems like a game of chance, beneficial for some, yet elusive for others. Enter machine learning—a revelation poised to change the rules of engagement, offering patients treatment
Could a routine mammogram hold more information than meets the eye? With the advent of artificial intelligence (AI), the potential to transform mammogram analysis into a tool for accurately predicting breast cancer risk is now a tangible reality. This game-changing development has emerged as a
The convergence of artificial intelligence and robotics promises significant advances in modern medicine, a topic recently underscored by the successful patient enrollment in the CANSCAN clinical trial. Spearheaded by Vexev, a prominent Australian medical device company, and U.S. Renal Care, this
Schizophrenia and severe mental illnesses present daunting challenges for the medical community, often leading to a fragmented understanding of their neurological underpinnings. This dilemma has inspired significant research efforts, one of the most revolutionary being the Living Brain Project
In a world where technology increasingly intersects with human cognitive abilities, Ivan Kairatov, a renowned figure in biopharma and innovation, shares insights into a groundbreaking development. His team's research on a home-based, AI-powered brain stimulation system aims to enhance concentration
